With Manitoba announcing it will provide full coverage for Mifegymiso, Saskatchewan is now the only province in the country that doesn’t, which is something the NDP believes needs to change.
“This Sask. Party government has stalled on providing coverage for this important and cost-effective drug at every turn, and now Saskatchewan is at the back of the pack,” said NDP Health Critic Vicki Mowat. “The evidence is clear that it’s cheaper and safer. And the need is there, especially in rural and remote parts of the province, but still this government resists providing better access for women. Instead of leading, we are once again falling way behind.”